Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Smid

Showing results (41-50 of 128) with videos related to

Pageof 13
Sort By:
Cell Communication and Signaling : CCS|January 23, 2023
GRHL2-controlled gene expression networks in luminal breast cancerZi Wang, Bircan Coban, Haoyu Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2019
Clonality, Antigen Recognition, and Suppression of CD8<sup>+</sup> T Cells Differentially Affect Prognosis of Breast Cancer SubtypesDora Hammerl, Maarten P G Massink, Marcel Smid, et al.
Oncotarget|September 4, 2018
Correction: MicroRNA expression in pre-treatment plasma of patients with benign breast diseases and breast cancerMirelle Lagendijk, Sepideh Saadatmand, Linetta B Koppert, et al.
Breast Cancer Research : BCR|July 3, 2019
A kinase inhibitor screen identifies a dual cdc7/CDK9 inhibitor to sensitise triple-negative breast cancer to EGFR-targeted therapyRonan P McLaughlin, Jichao He, Vera E van der Noord, et al.
Oncotarget|June 1, 2018
MicroRNA expression in pre-treatment plasma of patients with benign breast diseases and breast cancerMirelle Lagendijk, Sepideh Sadaatmand, Linetta B Koppert, et al.
Proteomics|April 1, 2016
The advantage of laser-capture microdissection over whole tissue analysis in proteomic profiling studiesTommaso De Marchi, Rene B H Braakman, Christoph Stingl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Relevance of breast cancer antiestrogen resistance genes in human breast cancer progression and tamoxifen resistanceTon van Agthoven, Anieta M Sieuwerts, Marion E Meijer-van Gelder, et al.
Data in Brief|March 10, 2016
Global proteomic characterization of microdissected estrogen receptor positive breast tumorsTommaso De Marchi, Ning Qing Liu, Christoph Sting, et al.
Oncogene|April 3, 2020
Integrative analysis of genomic amplification-dependent expression and loss-of-function screen identifies ASAP1 as a driver gene in triple-negative breast cancer progressionJichao He, Ronan P McLaughlin, Lambert van der Beek, et al.
Breast Cancer Research and Treatment|March 21, 2008
Functional identification of genes causing estrogen independence of human breast cancer cellsTon van Agthoven, Jos Veldscholte, Marcel Smid, et al.
Pageof 13

Showing results (41-50 of 128) with videos related to

Sort By:
Pageof 13
Cell Communication and Signaling : CCS|January 23, 2023
GRHL2-controlled gene expression networks in luminal breast cancerZi Wang, Bircan Coban, Haoyu Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2019
Clonality, Antigen Recognition, and Suppression of CD8<sup>+</sup> T Cells Differentially Affect Prognosis of Breast Cancer SubtypesDora Hammerl, Maarten P G Massink, Marcel Smid, et al.
Oncotarget|September 4, 2018
Correction: MicroRNA expression in pre-treatment plasma of patients with benign breast diseases and breast cancerMirelle Lagendijk, Sepideh Saadatmand, Linetta B Koppert, et al.
Breast Cancer Research : BCR|July 3, 2019
A kinase inhibitor screen identifies a dual cdc7/CDK9 inhibitor to sensitise triple-negative breast cancer to EGFR-targeted therapyRonan P McLaughlin, Jichao He, Vera E van der Noord, et al.
Oncotarget|June 1, 2018
MicroRNA expression in pre-treatment plasma of patients with benign breast diseases and breast cancerMirelle Lagendijk, Sepideh Sadaatmand, Linetta B Koppert, et al.
Proteomics|April 1, 2016
The advantage of laser-capture microdissection over whole tissue analysis in proteomic profiling studiesTommaso De Marchi, Rene B H Braakman, Christoph Stingl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Relevance of breast cancer antiestrogen resistance genes in human breast cancer progression and tamoxifen resistanceTon van Agthoven, Anieta M Sieuwerts, Marion E Meijer-van Gelder, et al.
Data in Brief|March 10, 2016
Global proteomic characterization of microdissected estrogen receptor positive breast tumorsTommaso De Marchi, Ning Qing Liu, Christoph Sting, et al.
Oncogene|April 3, 2020
Integrative analysis of genomic amplification-dependent expression and loss-of-function screen identifies ASAP1 as a driver gene in triple-negative breast cancer progressionJichao He, Ronan P McLaughlin, Lambert van der Beek, et al.
Breast Cancer Research and Treatment|March 21, 2008
Functional identification of genes causing estrogen independence of human breast cancer cellsTon van Agthoven, Jos Veldscholte, Marcel Smid, et al.
Pageof 13